APC was downgraded from Outperform to Perform, Oppenheimer said. Company has potential financial liabilities to the oil spill.
DIS was upgraded from Sell to Hold, Citigroup said. $37 price target. Valuation call, following the strong quarter, driven by Studio results.
HBAN was upgraded from Equal-weight to Overweight, Morgan Stanley said. Company is highly leveraged to improving credit trends. $8.50 price target.
HLIT coverage resumed with a Neutral rating and $7 price target. HLIT announced Omneon deal in 1Q10, now focus on integration, Bank of America/Merrill Lynch said.
MCK was upgraded from Neutral to Buy, Goldman Sachs. Stock was also added to the Conviction List. Company has tailwinds, without significant exposure to Europe.
MI was upgraded from Equal-weight to Overweight, Morgan Stanley said. $12 price target. Company has leverage to the credit market.
NAL was downgraded from Equal-weight to Underweight, Morgan Stanley said. Company has less leverage to improving credit trends.
NLC upgraded at JP Morgan. Rating raised to $30 from $25. Maintains 2010 EPS estimates of $1.22.
RT upgraded to Outperform from Neutral as top-line trends continue to improve, Credit Suisse said. Price target increased a dollar to $14.
SIVB was downgraded from Overweight to Equal-weight, Morgan Stanley said. $57 price target. Company has less exposure to the improving credit environment.
STZ was upgraded from Hold to Buy, Deutsche Bank said. $23 price target. Domestic wine and beer business appears to be improving.
TLAB upgraded to Neutral from Underperform on strong 1Q10 results, Bank of America/Merrill Lynch said. Price target lifted from $7.15 to $10.
Shares of AGO now seen reaching $27, UBS said. Estimates also lowered, given lower production rates and tighter credit spreads. Buy rating.
Church & Dwight price target boosted at Barclays
CHD price target increased to $69 from $65. CHD gaining market share just as consumer demand begins to recover, Barclays said. Equal Weight rating.
CHD price target increased to $69 from $65. CHD gaining market share just as consumer demand begins to recover, Barclays said. Equal Weight rating.
Shares of CHD now seen reaching $70, according to Goldman Sachs. Estimates also lowered, given higher expected promotional spending. Neutral rating.
Shares of CNK now seen reaching $15, according to Morgan Stanley. Estimates also upped, following the company's positive first-quarter results. Underweight rating.
DKS price target jumped to $32 from $28. The supply and demand landscape is supporting near and long term growth, Barclays said. Overweight rating.
ERTS estimates were cut through 2012, UBS said. Compnay is seeing weaker demand for packaged goods in Europe. Buy rating and $23 price target.
Shares of ESRX now seen reaching $124, Goldman Sachs said. Company can deliver superior earnings growth over the next couple of years. Buy rating.
GME estimates were lowered through 2011, according to Goldman Sachs. Company will be hurt by recent currency changes. Neutral rating.
HD price target increased to $39 from $34 ahead of 1Q10 results next Tuesday, Barclays said. 2011 and 2012 EPS estimates lifted to $1.83 and $2.24, respectively. Overweight rating.
LOW price target increased to $30 from $25 as Barclays expects good 1Q10 results next Monday. 2011 and 2012 EPS estimates set at $1.46 and $1.73, respectively.
MAT estimates were lowered through 2011, according to UBS. Company is facing higher input costs and currency pressure. Buy rating and $30 price target.
ODP estimates were cut through 2012, Goldman Sachs said. Company will be hurt by currency moves. Neutral rating.
ONNN estimates were boosted through 2012, Morgan Stanley said. Company facing lower interest costs, after paying down debt. Underweight rating.
PEP was added to the Conviction Buy list, Goldman Sachs said. Earnings growth should reaccelerate, even though the company faces currency pressure. Buy rating and $76 price target.
Shares of PGN now seen reaching $42, according to Morgan Stanley. Estimates also increased, following a positive rate case in Florida. Equal-weight rating.
PM was removed from the Conviction Buy list, Goldman Sachs said. Estimates also lowered, given recent currency moves. $59 price target.
SPWRA estimates were reduced through 2011, according to UBS. Company guided to lower solar roof top sales. Neutral rating and new $17 price target.
TWTC estimates were raised through 2012, Morgan Stanley said. Company posted record-low churn for the quarter and is seeing robust bookings activity. Equal-weight rating.